![Mark Bogart](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Bogart
President chez Biomedical Patent Management Corp.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Dick L. Sherman | M | 76 |
Hawaii Biotech, Inc.
![]() Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | - |
Adelheid R. Kuehnle | M | - |
Kuehnle AgroSystems, Inc.
![]() Kuehnle AgroSystems, Inc. Miscellaneous Commercial ServicesCommercial Services Kuehnle AgroSystems, Inc. develops algae strains for use in bio fuel and chemical production. It develops and produce algae based solutions for skin and personal care, specialty chemicals, wastewater treatment with CO2 capture and aquaculture & animal nutrition. The company was founded by Paul S. Zorner, Adelheid R. Kuehnle and Gordon O. Wallace in 1998 and is headquartered in Honolulu, H | 26 ans |
Gordon O. Wallace | M | - |
Kuehnle AgroSystems, Inc.
![]() Kuehnle AgroSystems, Inc. Miscellaneous Commercial ServicesCommercial Services Kuehnle AgroSystems, Inc. develops algae strains for use in bio fuel and chemical production. It develops and produce algae based solutions for skin and personal care, specialty chemicals, wastewater treatment with CO2 capture and aquaculture & animal nutrition. The company was founded by Paul S. Zorner, Adelheid R. Kuehnle and Gordon O. Wallace in 1998 and is headquartered in Honolulu, H | 26 ans |
Laurence Knutson | M | - |
Hawaii Biotech, Inc.
![]() Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | - |
Albert H. Pleus | M | - |
Kuehnle AgroSystems, Inc.
![]() Kuehnle AgroSystems, Inc. Miscellaneous Commercial ServicesCommercial Services Kuehnle AgroSystems, Inc. develops algae strains for use in bio fuel and chemical production. It develops and produce algae based solutions for skin and personal care, specialty chemicals, wastewater treatment with CO2 capture and aquaculture & animal nutrition. The company was founded by Paul S. Zorner, Adelheid R. Kuehnle and Gordon O. Wallace in 1998 and is headquartered in Honolulu, H | - |
Debra R. Guerin Beresini | F | - |
Hawaii Biotech, Inc.
![]() Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | - |
Robert J. Robinson | M | - |
Hawaii Biotech, Inc.
![]() Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | - |
Michele L. Yelmene | F | 60 |
Hawaii Biotech, Inc.
![]() Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | - |
Enrique Carrazana | M | 62 |
Hawaii Biotech, Inc.
![]() Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | - |
David E. Clements | M | - |
Hawaii Biotech, Inc.
![]() Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | 37 ans |
Jennifer Murata | F | - |
Hawaii Biotech, Inc.
![]() Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | - |
Carsten Krome | M | - |
Kuehnle AgroSystems, Inc.
![]() Kuehnle AgroSystems, Inc. Miscellaneous Commercial ServicesCommercial Services Kuehnle AgroSystems, Inc. develops algae strains for use in bio fuel and chemical production. It develops and produce algae based solutions for skin and personal care, specialty chemicals, wastewater treatment with CO2 capture and aquaculture & animal nutrition. The company was founded by Paul S. Zorner, Adelheid R. Kuehnle and Gordon O. Wallace in 1998 and is headquartered in Honolulu, H | 4 ans |
Claude Kaplan | M | - |
Kuehnle AgroSystems, Inc.
![]() Kuehnle AgroSystems, Inc. Miscellaneous Commercial ServicesCommercial Services Kuehnle AgroSystems, Inc. develops algae strains for use in bio fuel and chemical production. It develops and produce algae based solutions for skin and personal care, specialty chemicals, wastewater treatment with CO2 capture and aquaculture & animal nutrition. The company was founded by Paul S. Zorner, Adelheid R. Kuehnle and Gordon O. Wallace in 1998 and is headquartered in Honolulu, H | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 13 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Mark Bogart
- Réseau Personnel